Showing results (61-70 of 5,960) with videos related to
Sort By:
Pageof 596
Current Opinion in Nephrology and Hypertension|August 19, 2007
Protein kinase C beta inhibition: the promise for treatment of diabetic nephropathyPamela W Anderson, Janet B McGill, Katherine R TuttleAmerican Journal of Physiology. Renal Physiology|August 16, 2018
GLP-1 receptor agonists in diabetic kidney disease: from the patient-side to the bench-sideBrad P Dieter, Radica Z Alicic, Katherine R TuttleAdvances in Chronic Kidney Disease|March 28, 2018
Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney DiseaseRadica Z Alicic, Emily J Johnson, Katherine R TuttleBiological Cybernetics|January 1, 1981
Principal components analysis of sources of variability in retinal ganglion cell responsesR M Chapman, J W McCrary, J R TuttleMetabolism: Clinical and Experimental|February 1, 1992
Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetesS M Haffner, K R Tuttle, D L RainwaterAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 6, 2018
SGLT2 Inhibition for the Prevention and Treatment of Diabetic Kidney Disease: A ReviewRadica Z Alicic, Emily J Johnson, Katherine R TuttleCurrent Opinion in Nephrology and Hypertension|May 17, 2023
Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney diseaseRadica Z Alicic, Joshua J Neumiller, Katherine R TuttleDiabetes Care|April 1, 1991
Decrease of lipoprotein(a) with improved glycemic control in IDDM subjectsS M Haffner, K R Tuttle, D L RainwaterCardiovascular Research|July 1, 1976
Differential beta adrenergic sensitivity of atrial and ventricular tissue assessed by chronotropic, inotropic, and cyclic AMP responses to isoprenaline and dobutamineR R Tuttle, C C Hillmann, R E ToomeyPageof 596